Liquid Facelift in Istanbul: An Individualised Injectable Assessment

Liquid facelift in Istanbul is an umbrella phrase for planning one or more injectable treatments around different facial concerns. It is not one product, a standardised protocol or an equivalent to surgical facelift.

What does the term include?

The label is commonly used for a nonsurgical assessment of volume change, expression lines and facial contour. Hyaluronic acid filler adds volume or support; botulinum toxin is not a filler but a medicine that temporarily reduces selected muscle activity. The FDA patient resource distinguishes these product classes. Other injectables, such as calcium hydroxylapatite or poly-L-lactic acid, have different properties and are not interchangeable with HA.

Why is there no universal protocol?

Facial ageing is not simply a loss of volume. Skin quality, bone support, fat compartments, muscle movement and tissue laxity vary between people. Published expert recommendations on combination treatment likewise stress tailoring decisions to anatomy and goals. A product list or fixed number of treatment areas found online is not a safe personal plan.

Who might be considered?

Assessment may suit someone with mild or moderate volume change, selected expression lines or a contour concern who understands that change is limited and temporary. Active infection, pregnancy or breastfeeding, certain neuromuscular conditions, bleeding problems, severe allergy history or a previous injectable complication may alter eligibility. Suitability must be judged separately for every product and anatomical area.

Does it replace surgery?

No. A surgical facelift described by the NHS lifts and repositions loose tissue and may remove excess skin. Injectables neither remove skin nor mechanically correct substantial laxity. Alternatives can include observation, skin care, energy-based procedures, focused regional treatment, thread-lift assessment or a surgical consultation, depending on the finding.

Preparation, staging and follow-up

Bring the names and dates of previous products, relevant medical history and a current medication list. Do not stop prescribed medicines without advice from the responsible clinician. For some people, recommending no procedure or separating treatments across visits is more appropriate. Early swelling is not the final outcome. Follow-up reviews contour, expression, symmetry and adverse effects; degree and duration of change cannot be guaranteed.

Risks and urgent warning signs

Fillers can cause bruising, swelling, irregularity, nodules, infection and, rarely, vascular occlusion. Botulinum toxin can cause unwanted muscle weakness, brow or eyelid droop; these are different risks. The FDA reports visual loss or stroke after filler enters a vessel and rare swallowing or breathing difficulty with botulinum toxin products. After filler injection, unusual pain, sudden vision changes, an abnormal white, grey or blue change in skin near the injection site, or neurological symptoms require immediate emergency care. Trouble swallowing or breathing after botulinum toxin also needs immediate emergency care. Do not wait for a routine appointment. Stable elective goals can be discussed at the Istanbul Maslak clinic.

Related guides

• Dermal Fillers
• Botulinum Toxin
• Thread Lift Guide

Sources

• FDA — Dermal Filler Do's and Don'ts for Wrinkles, Lips and More
• NHS — Facelift (rhytidectomy)
• Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies

This content provides general information, not a diagnosis or personal treatment recommendation. Suitability, risks and alternatives require an individual medical assessment.

The cover is an AI-generated conceptual illustration; it does not show a patient or treatment result.